Pea F.; Cojutti P.; Dose L.; Furian C.; Guarrera G.; Furlanut M., Personalization of antimicrobial dosing regimens: Indicators of performance, «ITALIAN JOURNAL OF PUBLIC HEALTH», 2012, 9, pp. 1 - 5 [articolo]
Pea F; Cojutti P; Pagotto A; Cristini F; Furlanut M; Viale P, Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy., «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2012, 56, pp. 3438 - 3440 [articolo]
Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M, Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients., «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2012, 67, pp. 2034 - 2042 [articolo]
Pea, Federico; Cojutti, Piergiorgio; Petrosillo, Nicola; Furlanut, Mario; Entenza, J M; Veloso, T R; Vouillamoz, J; Giddey, M; Moreillon, P, Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2011, 55, pp. 4496 - 4497 [replica/breve intervento]
Pea F.; Cojutti P.; Sbrojavacca R.; Cadeo B.; Cristini F.; Bulfoni A.; Furlanut M., TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient, «THE ANNALS OF PHARMACOTHERAPY», 2011, 45, pp. e37 - 1022 [articolo]
Pea F; Furlanut M; Cojutti P; Cristini F; Zamparini E; Franceschi L; Viale P., Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis., «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2010, 54, pp. 4605 - 4610 [articolo]
Pea F.; Baccarani U.; Tavio M.; Cojutti P.; Adani G.L.; Londero A.; Baraldo M.; Franceschi L.; Furlanut M.; Viale P., Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient, «THE ANNALS OF PHARMACOTHERAPY», 2008, 42, pp. 1711 - 1716 [articolo]
